-
1
-
-
0025836321
-
Clinical implications of positive and negative hematopoietic stem cell regulators
-
Moore MAS. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991;78:1-19.
-
(1991)
Blood
, vol.78
, pp. 1-19
-
-
Moore, M.A.S.1
-
3
-
-
0028338616
-
Hematopoietic growth factors in cancer treatment
-
Büchner T. Hematopoietic growth factors in cancer treatment. STEM CELLS 1994;12:241-252.
-
(1994)
STEM CELLS
, vol.12
, pp. 241-252
-
-
Büchner, T.1
-
4
-
-
0027371503
-
Ways of minimizing hematopoietic damage induced by radiation and cytostatic drugs - The possible role of inhibitors
-
Tubiana M, Carde P, Frindel E. Ways of minimizing hematopoietic damage induced by radiation and cytostatic drugs - the possible role of inhibitors. Radiother Oncol 1993;29:1-17.
-
(1993)
Radiother Oncol
, vol.29
, pp. 1-17
-
-
Tubiana, M.1
Carde, P.2
Frindel, E.3
-
5
-
-
0029565872
-
Inhibitors of haemopoiesis and their potential clinical relevance
-
Parker AN, Pragnell IB. Inhibitors of haemopoiesis and their potential clinical relevance. Blood Rev 1995;9:226-233.
-
(1995)
Blood Rev
, vol.9
, pp. 226-233
-
-
Parker, A.N.1
Pragnell, I.B.2
-
6
-
-
0001645294
-
Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure
-
Lenfant M, Wdzieczak-Bakala J, Guittet E et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci USA 1989;86:779-782.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 779-782
-
-
Lenfant, M.1
Wdzieczak-Bakala, J.2
Guittet, E.3
-
8
-
-
0026447759
-
The mechanism of action of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation
-
Robinson S, Lenfant M, Wdzieczak-Bakala J et al. The mechanism of action of the tetrapeptide Acelyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation. Cell Prolif 1992;25:623-632.
-
(1992)
Cell Prolif
, vol.25
, pp. 623-632
-
-
Robinson, S.1
Lenfant, M.2
Wdzieczak-Bakala, J.3
-
9
-
-
0025202850
-
Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP
-
Guigon M, Bonnet D, Lemoine F et al. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp Hematol 1990;18:1112-1115.
-
(1990)
Exp Hematol
, vol.18
, pp. 1112-1115
-
-
Guigon, M.1
Bonnet, D.2
Lemoine, F.3
-
10
-
-
0029933423
-
Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitors in short-term and long-term murine bone marrow cultures
-
Jackson JD, Yan Y, Ewel C et al. Activity of Acetyl-Ser-Asp-Lys-Pro (AcSDKP) on hematopoietic progenitors in short-term and long-term murine bone marrow cultures. Exp Hematol 1996;24:475-481.
-
(1996)
Exp Hematol
, vol.24
, pp. 475-481
-
-
Jackson, J.D.1
Yan, Y.2
Ewel, C.3
-
11
-
-
0026500752
-
The tetrapeptide AcSDKP, an inhibitor of cell cycle status for normal human hematopoietic progenitors has no effect on leukemic cells
-
Bonnet D, Cesaire R, Lemoine F et al. The tetrapeptide AcSDKP, an inhibitor of cell cycle status for normal human hematopoietic progenitors has no effect on leukemic cells. Exp Hematol 1992;20:251-255.
-
(1992)
Exp Hematol
, vol.20
, pp. 251-255
-
-
Bonnet, D.1
Cesaire, R.2
Lemoine, F.3
-
12
-
-
0028022981
-
The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism
-
Cashman JD, Eaves AC, Eaves CJ. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism. Blood 1994;84:1534-1542.
-
(1994)
Blood
, vol.84
, pp. 1534-1542
-
-
Cashman, J.D.1
Eaves, A.C.2
Eaves, C.J.3
-
13
-
-
0027731190
-
Influence of the peptide AcSerAspLysPro, an hematopoietic inhibitor, on 3′-azido-3′-deoxythymidine-induced in vitro toxicity on human hematopoietic progenitors
-
Grillon C, Bonnet D, Mary JY et al. Influence of the peptide AcSerAspLysPro, an hematopoietic inhibitor, on 3′-azido-3′-deoxythymidine-induced in vitro toxicity on human hematopoietic progenitors. STEM CELLS 1993;11:455-464.
-
(1993)
STEM CELLS
, vol.11
, pp. 455-464
-
-
Grillon, C.1
Bonnet, D.2
Mary, J.Y.3
-
14
-
-
0030035025
-
The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654)
-
Genevay MC, Mormont C, Thomas F et al. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654). Exp Hematol 1996;24:77-81.
-
(1996)
Exp Hematol
, vol.24
, pp. 77-81
-
-
Genevay, M.C.1
Mormont, C.2
Thomas, F.3
-
15
-
-
0028028104
-
Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP
-
Coutton C, Guigon M, Bohbot A et al. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP. Exp Hematol 1994;22:1076-1080.
-
(1994)
Exp Hematol
, vol.22
, pp. 1076-1080
-
-
Coutton, C.1
Guigon, M.2
Bohbot, A.3
-
16
-
-
0029976447
-
Goralatide (AcSDKP) selectively protects mutine hematopoietic progenitors and stem cells against hyperthermic damage
-
Wierenga P, Konings AWT. Goralatide (AcSDKP) selectively protects mutine hematopoietic progenitors and stem cells against hyperthermic damage. Exp Hematol 1996;24:246-252.
-
(1996)
Exp Hematol
, vol.24
, pp. 246-252
-
-
Wierenga, P.1
Konings, A.W.T.2
-
17
-
-
0030701945
-
Reduction of heat induced haematoxicity in a hyperthermic purging protocol of murine acute myeloid leukemic cells by AcSDKP (Goralatide)
-
Wierenga PK, Dillingh JH, Konings AWT. Reduction of heat induced haematoxicity in a hyperthermic purging protocol of murine acute myeloid leukemic cells by AcSDKP (Goralatide). Br J Haematol 1997;99:692-698,
-
(1997)
Br J Haematol
, vol.99
, pp. 692-698
-
-
Wierenga, P.K.1
Dillingh, J.H.2
Konings, A.W.T.3
-
18
-
-
0031982923
-
Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression
-
Wierenga PK, Brenner MK, Konings AWT. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Bone Marrow Transplant 1998;21:73-78.
-
(1998)
Bone Marrow Transplant
, vol.21
, pp. 73-78
-
-
Wierenga, P.K.1
Brenner, M.K.2
Konings, A.W.T.3
-
19
-
-
0025873352
-
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation
-
Bogden AE, Carde P, Deschamps de Paillette E et al. Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Ann NY Acad Sci 1991;628:126-139.
-
(1991)
Ann NY Acad Sci
, vol.628
, pp. 126-139
-
-
Bogden, A.E.1
Carde, P.2
Deschamps De Paillette, E.3
-
20
-
-
0029841318
-
In vivo effect of Platelet Factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil
-
Aidoudi S, Guigon M, Lebburier I et al. In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil. Br J Haematol 1996;94:443-448.
-
(1996)
Br J Haematol
, vol.94
, pp. 443-448
-
-
Aidoudi, S.1
Guigon, M.2
Lebburier, I.3
-
21
-
-
0029975460
-
In vivo protective effects of tetrapeptide AcSDKP with or without gramilocyte colony-stimulating factor on murine progenitor cells following sublethal irradiation
-
Watanabe T, Brown GS, Kelsey LS et al. In vivo protective effects of tetrapeptide AcSDKP with or without gramilocyte colony-stimulating factor on murine progenitor cells following sublethal irradiation. Exp Hematol 1996;24:713-721.
-
(1996)
Exp Hematol
, vol.24
, pp. 713-721
-
-
Watanabe, T.1
Brown, G.S.2
Kelsey, L.S.3
-
22
-
-
0030890442
-
In vivo radioprotective effect of AcSDKP on canine myelopoiesis
-
Deeg HJ, Seidel K, Hong DS et al. In vivo radioprotective effect of AcSDKP on canine myelopoiesis. Ann Hematol 1997;74:117-122.
-
(1997)
Ann Hematol
, vol.74
, pp. 117-122
-
-
Deeg, H.J.1
Seidel, K.2
Hong, D.S.3
-
23
-
-
0344732253
-
In vivo effects of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (Seraspenide) on hematopoiesis of normal primates and mice
-
Guigon M, Lemoine F, Dainiak N et al., eds. Paris: Colloque INSERM/John Libbey Eurotext Ltd.
-
Herodin F, Grognier JM, Mestries JC et al. In vivo effects of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (Seraspenide) on hematopoiesis of normal primates and mice. In: Guigon M, Lemoine F, Dainiak N et al., eds. The Negative Regulation of Hematopoiesis, from Fundamenlal Aspects to Clinical Applications. Paris: Colloque INSERM/John Libbey Eurotext Ltd., 1993:189.
-
(1993)
The Negative Regulation of Hematopoiesis, from Fundamenlal Aspects to Clinical Applications
, pp. 189
-
-
Herodin, F.1
Grognier, J.M.2
Mestries, J.C.3
-
24
-
-
0031970707
-
Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF
-
Bogden AE, Moreau JP, Gamba-Vitalo C et al. Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF. Int J Cancer 1998;76:38-46.
-
(1998)
Int J Cancer
, vol.76
, pp. 38-46
-
-
Bogden, A.E.1
Moreau, J.P.2
Gamba-Vitalo, C.3
-
25
-
-
0031962948
-
The tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects mice from doxorubicin-induced toxicity: An improvement in both survival and hematological protection for early marrow stem cells and progenitors
-
Masse A, Ramirez LH, Bindoula G et al. The tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects mice from doxorubicin-induced toxicity: an improvement in both survival and hematological protection for early marrow stem cells and progenitors. Blood 1998;91:441-449.
-
(1998)
Blood
, vol.91
, pp. 441-449
-
-
Masse, A.1
Ramirez, L.H.2
Bindoula, G.3
-
26
-
-
0027035935
-
Séraspénide (AcSDKP): Etude en phase I-II d'un inhibiteur de l'hématopoïèse la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide
-
Carde P, Chastang C, Concalves E et al. Séraspénide (AcSDKP): Etude en phase I-II d'un inhibiteur de l'hématopoïèse la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide. C R Acad Sci Paris série III 1992;315:545-550.
-
(1992)
C R Acad Sci Paris Série III
, vol.315
, pp. 545-550
-
-
Carde, P.1
Chastang, C.2
Concalves, E.3
-
27
-
-
0027432429
-
Involvement of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide NAc-Ser-Asp-Lys-Pro
-
Rieger K, Saez-Servent N, Papet MP et al. Involvement of human plasma angiotensin converting enzyme in the degradation of the hemoregulatory peptide NAc-Ser-Asp-Lys-Pro. Biochem J 1993;296:373-378.
-
(1993)
Biochem J
, vol.296
, pp. 373-378
-
-
Rieger, K.1
Saez-Servent, N.2
Papet, M.P.3
-
28
-
-
0014957830
-
A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin
-
Yang HYT, Erdos EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374-376.
-
(1970)
Biochim Biophys Acta
, vol.214
, pp. 374-376
-
-
Yang, H.Y.T.1
Erdos, E.G.2
Levin, Y.3
-
29
-
-
0000110931
-
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning
-
Soubrier F, Alhenc-Gelas F, Hubert C et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-9390.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 9386-9390
-
-
Soubrier, F.1
Alhenc-Gelas, F.2
Hubert, C.3
-
30
-
-
0028967315
-
The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal site of human angiotensin-converting enzyme
-
Rousseau A, Michaud A, Chauvet MT et al. The hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal site of human angiotensin-converting enzyme. J Biol Chem 1995;270:3656-3661.
-
(1995)
J Biol Chem
, vol.270
, pp. 3656-3661
-
-
Rousseau, A.1
Michaud, A.2
Chauvet, M.T.3
-
31
-
-
0030434802
-
Single-domain angiotensin I converting enzyme (Kininase II): Characterization and properties
-
Deddish PA, Wang LX, Jackman HL et al. Single-domain angiotensin I converting enzyme (Kininase II): characterization and properties. J Pharmacol Exp Ther 1996;279:1582-1589.
-
(1996)
J Pharmacol Exp Ther
, vol.279
, pp. 1582-1589
-
-
Deddish, P.A.1
Wang, L.X.2
Jackman, H.L.3
-
32
-
-
0030027331
-
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline
-
Azizi M, Rousseau A, Ezan E et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 1996;97:839-844.
-
(1996)
J Clin Invest
, vol.97
, pp. 839-844
-
-
Azizi, M.1
Rousseau, A.2
Ezan, E.3
-
33
-
-
0028172132
-
Pharmacokinetics in healthy volunteers and patients of NacSDKP (Seraspenide), a negative regulator of hematopoiesis
-
Ezan E, Carde P, Le Kerneau J et al. Pharmacokinetics in healthy volunteers and patients of NacSDKP (Seraspenide), a negative regulator of hematopoiesis. Drug Metab Disp 1994;22:843-848.
-
(1994)
Drug Metab Disp
, vol.22
, pp. 843-848
-
-
Ezan, E.1
Carde, P.2
Le Kerneau, J.3
-
34
-
-
0030773559
-
NAcSDKP analogues resistant to angiotensin-converting enzyme
-
Gaudron S, Adeline MT, Potier P et al. NAcSDKP analogues resistant to angiotensin-converting enzyme. J Med Chem 1997;40:3963-3968.
-
(1997)
J Med Chem
, vol.40
, pp. 3963-3968
-
-
Gaudron, S.1
Adeline, M.T.2
Potier, P.3
-
35
-
-
0025350502
-
Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation
-
Thierry J, Papet MP, Saez-Servent N et al. Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation. J Med Chem 1990;33:2122-2127.
-
(1990)
J Med Chem
, vol.33
, pp. 2122-2127
-
-
Thierry, J.1
Papet, M.P.2
Saez-Servent, N.3
-
36
-
-
0024852475
-
Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T lymphocytes in AcSDKP response
-
Monpezat JP, Frindel E. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T lymphocytes in AcSDKP response. Exp Hematol 1989;17:1077-1080.
-
(1989)
Exp Hematol
, vol.17
, pp. 1077-1080
-
-
Monpezat, J.P.1
Frindel, E.2
-
37
-
-
0031766812
-
In vivo effect of Goralatide after 5-fluorouracil administration on murine hematopoiesis and AcSDKP metabolism
-
Comte L, Lorgeot V, Bignon J et al. In vivo effect of Goralatide after 5-fluorouracil administration on murine hematopoiesis and AcSDKP metabolism. Eur J Clin Invest 1998;20:856-863.
-
(1998)
Eur J Clin Invest
, vol.20
, pp. 856-863
-
-
Comte, L.1
Lorgeot, V.2
Bignon, J.3
-
38
-
-
0004145024
-
A new physiological role of ACE in the regulation of hematopoiesis?
-
Wdzieczak-Bakala J, Rousseau A, Robinson S et al. A new physiological role of ACE in the regulation of hematopoiesis? STEM CELLS 1995;13:566.
-
(1995)
STEM CELLS
, vol.13
, pp. 566
-
-
Wdzieczak-Bakala, J.1
Rousseau, A.2
Robinson, S.3
-
39
-
-
0028913481
-
AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia
-
Liozon E, Volkov L, Comte L et al. AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia. Br J Haematol 1995;89:917-920.
-
(1995)
Br J Haematol
, vol.89
, pp. 917-920
-
-
Liozon, E.1
Volkov, L.2
Comte, L.3
-
40
-
-
0021833338
-
Enkephalin pseudopeptides: Resistance to in vitro proleolytic degradation afforded by amide bond replacement extends to remote sites
-
Benovitz DE, Spatola AF. Enkephalin pseudopeptides: resistance to in vitro proleolytic degradation afforded by amide bond replacement extends to remote sites. Peptides 1985;6:257-261.
-
(1985)
Peptides
, vol.6
, pp. 257-261
-
-
Benovitz, D.E.1
Spatola, A.F.2
-
41
-
-
0027716794
-
The molecular specificity of action of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation
-
Robinson S, Lenfant M, Wdzieczak-Bakala J et al. The molecular specificity of action of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation. STEM CELLS 1993;11:422-427.
-
(1993)
STEM CELLS
, vol.11
, pp. 422-427
-
-
Robinson, S.1
Lenfant, M.2
Wdzieczak-Bakala, J.3
|